USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Aug 3, 2022 (est) | Jun 30, 2022 | - | - | $3.90 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Aug 3, 2022 (est) | Jun 30, 2022 | - | - | $751.81M |
Jazz Pharmaceuticals's next estimated earnings date (based on same quarter last year's date) is Aug 3, 2022 for the fiscal quarter ending Jun 30, 2022.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Jun 2022 | 16 | $4.40 | $4.05 | $4.87 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 18 | $16.53 | $15.92 | $17.58 |
| Dec 2023 | 17 | $17.44 | $12.87 | $22.16 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Jun 2022 | 4 / 0 | $4.27 | $4.08 | $3.97 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2022 | 2 / 1 | $16.51 | $17.49 | $17.46 |
| Dec 2023 | 1 / 1 | $17.79 | $18.84 | $18.64 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Jun 2022 | 14 | $911.64M | $857.64M | $952.10M |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 18 | $3.59B | $3.50B | $3.67B |
| Dec 2023 | 18 | $3.80B | $3.43B | $4.30B |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| May 2, 2022 | Mar 2022 | $3.83 | - | - |
| Mar 1, 2022 | Dec 2021 | $3.64 | $4.21 | 15.66% |
| Nov 9, 2021 | Sep 2021 | $3.31 | $4.20 | 26.71% |
| Aug 3, 2021 | Jun 2021 | $3.45 | $3.90 | 13.15% |
| May 4, 2021 | Mar 2021 | $3.73 | $3.92 | 4.98% |
| Feb 23, 2021 | Dec 2020 | $4.20 | $4.00 | -4.82% |
| Nov 2, 2020 | Sep 2020 | $4.08 | $4.31 | 5.74% |
| Aug 4, 2020 | Jun 2020 | $3.11 | $3.71 | 19.20% |
| May 5, 2020 | Mar 2020 | $0.67 | $0.45 | -33.04% |
| Feb 25, 2020 | Dec 2019 | $4.12 | $4.42 | 7.27% |
| Nov 5, 2019 | Sep 2019 | $3.59 | $4.10 | 14.05% |
| Aug 6, 2019 | Jun 2019 | $3.57 | $4.05 | 13.39% |
| May 7, 2019 | Mar 2019 | $3.16 | $3.67 | 16.17% |
| Feb 26, 2019 | Dec 2018 | $3.03 | $3.64 | 20.22% |
| Nov 6, 2018 | Sep 2018 | $3.32 | $3.58 | 7.84% |
| Aug 7, 2018 | Jun 2018 | $3.21 | $3.49 | 8.75% |
| May 8, 2018 | Mar 2018 | $2.78 | $2.98 | 7.19% |
| Feb 27, 2018 | Dec 2017 | $2.96 | $2.95 | -0.39% |
| Nov 7, 2017 | Sep 2017 | $2.89 | $3.22 | 11.50% |
| Aug 8, 2017 | Jun 2017 | $2.75 | $2.56 | -6.93% |
| May 9, 2017 | Mar 2017 | $2.34 | $2.31 | -1.26% |
| Feb 28, 2017 | Dec 2016 | $2.65 | $2.71 | 2.12% |
| Nov 8, 2016 | Sep 2016 | $2.61 | $2.57 | -1.53% |
| Aug 9, 2016 | Jun 2016 | $2.81 | $2.63 | -6.32% |
| May 10, 2016 | Mar 2016 | $2.32 | $2.26 | -2.70% |
| Feb 23, 2016 | Dec 2015 | $2.60 | $2.60 | 0.14% |
| Nov 9, 2015 | Sep 2015 | $2.56 | $2.52 | -1.56% |
| Aug 5, 2015 | Jun 2015 | $2.41 | $2.41 | - |
| May 7, 2015 | Mar 2015 | $2.15 | $1.99 | -7.44% |
| Feb 24, 2015 | Dec 2014 | $2.30 | $2.44 | 6.09% |
| Nov 4, 2014 | Sep 2014 | $2.22 | $2.33 | 4.96% |
| Aug 5, 2014 | Jun 2014 | $1.92 | $2.05 | 6.77% |
| May 8, 2014 | Mar 2014 | $1.79 | $1.61 | -10.06% |
| Feb 25, 2014 | Dec 2013 | $1.78 | $1.72 | -3.37% |
| Nov 5, 2013 | Sep 2013 | $1.67 | $1.78 | 6.59% |
| Aug 6, 2013 | Jun 2013 | $1.52 | $1.43 | -5.92% |
| May 7, 2013 | Mar 2013 | $1.35 | $1.37 | 1.48% |
| Feb 26, 2013 | Dec 2012 | $1.42 | $1.53 | 7.75% |
| Nov 8, 2012 | Sep 2012 | $1.32 | $1.29 | -2.27% |
| Aug 7, 2012 | Jun 2012 | $1.05 | $1.09 | 3.81% |
| May 8, 2012 | Mar 2012 | $0.84 | $0.91 | 8.33% |
| Feb 27, 2012 | Dec 2011 | $1.09 | $1.17 | 7.34% |
| Nov 1, 2011 | Sep 2011 | $0.94 | $0.94 | - |
| Jul 28, 2011 | Jun 2011 | $0.79 | $0.82 | 3.80% |
| May 3, 2011 | Mar 2011 | $0.57 | $0.59 | 3.51% |
| Mar 7, 2011 | Dec 2010 | $0.60 | $0.63 | 5.00% |
| Nov 4, 2010 | Sep 2010 | $0.34 | $0.41 | 20.59% |
| Aug 10, 2010 | Jun 2010 | $0.14 | $0.28 | 100.00% |
| May 5, 2010 | Mar 2010 | $0.18 | $0.18 | - |
| Mar 3, 2010 | Dec 2009 | $0.07 | $0.17 | 142.86% |
| Nov 5, 2009 | Sep 2009 | $-0.14 | $-0.05 | 64.29% |
| Aug 11, 2009 | Jun 2009 | $-0.32 | $0.07 | 121.88% |
| May 7, 2009 | Mar 2009 | - | $-0.45 | - |
| Mar 26, 2009 | Dec 2008 | $-1.07 | $-2.04 | -90.65% |
| Nov 13, 2008 | Sep 2008 | $-1.29 | $-1.07 | 17.05% |
| Aug 7, 2008 | Jun 2008 | $-1.78 | $-2.17 | -21.91% |
| May 13, 2008 | Mar 2008 | $-1.57 | $-1.97 | -25.48% |
| Feb 13, 2008 | Dec 2007 | $-1.82 | $-1.69 | 7.14% |
| Nov 6, 2007 | Sep 2007 | $-1.40 | $-0.82 | 41.43% |
| Aug 9, 2007 | Jun 2007 | $-1.69 | $-1.38 | 18.34% |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 1, 2022 | Dec 2021 | $15.68 | $16.23 | 3.51% |
| Feb 23, 2021 | Dec 2020 | $12.60 | $12.47 | -1.03% |
| Feb 25, 2020 | Dec 2019 | $15.91 | $16.24 | 2.07% |
| Feb 26, 2019 | Dec 2018 | $13.07 | $13.69 | 4.74% |
| Feb 27, 2018 | Dec 2017 | $11.09 | $11.04 | -0.45% |
| Feb 28, 2017 | Dec 2016 | - | $10.17 | - |
| Feb 23, 2016 | Dec 2015 | - | $9.52 | - |
| Feb 24, 2015 | Dec 2014 | - | $8.43 | - |
| Feb 25, 2014 | Dec 2013 | - | $6.30 | - |
| Feb 26, 2013 | Dec 2012 | - | $4.82 | - |
| Feb 27, 2012 | Dec 2011 | - | $3.52 | - |
| Mar 7, 2011 | Dec 2010 | - | $1.50 | - |
| Mar 3, 2010 | Dec 2009 | - | $-0.26 | - |
| Mar 26, 2009 | Dec 2008 | - | $-7.25 | - |
| Feb 13, 2008 | Dec 2007 | - | $-3.89 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| May 2, 2022 | Mar 2022 | $854.18M | - | - |
| Mar 1, 2022 | Dec 2021 | $896.73M | $896.73M | 1.00% |
| Nov 9, 2021 | Sep 2021 | $834.83M | $838.12M | 1.00% |
| Aug 3, 2021 | Jun 2021 | $751.81M | $751.81M | 1.00% |
| May 4, 2021 | Mar 2021 | $607.58M | $607.58M | 1.00% |
| Feb 23, 2021 | Dec 2020 | $639.55M | $665.52M | 1.04% |
| Nov 2, 2020 | Sep 2020 | $577.58M | $600.89M | 1.04% |
| Aug 4, 2020 | Jun 2020 | $504.65M | $562.44M | 1.11% |
| May 5, 2020 | Mar 2020 | $544.55M | $534.73M | 0.98% |
| Feb 25, 2020 | Dec 2019 | $562.02M | $581.74M | 1.04% |
| Nov 5, 2019 | Sep 2019 | $525.16M | $537.70M | 1.02% |
| Aug 6, 2019 | Jun 2019 | $508.62M | $534.13M | 1.05% |
| May 7, 2019 | Mar 2019 | $465.95M | $508.19M | 1.09% |
| Feb 26, 2019 | Dec 2018 | $459.72M | $476.46M | 1.04% |
| Nov 6, 2018 | Sep 2018 | $482.48M | $469.37M | 0.97% |
| Aug 7, 2018 | Jun 2018 | $469.62M | $500.50M | 1.07% |
| May 8, 2018 | Mar 2018 | $435.46M | $444.60M | 1.02% |
| Feb 27, 2018 | Dec 2017 | $441.31M | $436.40M | 0.99% |
| Nov 7, 2017 | Sep 2017 | $421.00M | $411.90M | 0.98% |
| Aug 8, 2017 | Jun 2017 | $410.51M | $394.40M | 0.96% |
| May 9, 2017 | Mar 2017 | - | $376.10M | - |
| Feb 28, 2017 | Dec 2016 | - | $396.60M | - |
| Nov 8, 2016 | Sep 2016 | - | $374.20M | - |
| Aug 9, 2016 | Jun 2016 | - | $381.20M | - |
| May 10, 2016 | Mar 2016 | - | $336.00M | - |
| Feb 23, 2016 | Dec 2015 | - | $340.90M | - |
| Nov 9, 2015 | Sep 2015 | - | $340.90M | - |
| Aug 5, 2015 | Jun 2015 | - | $333.70M | - |
| May 7, 2015 | Mar 2015 | - | $309.30M | - |
| Feb 24, 2015 | Dec 2014 | - | $328.10M | - |
| Nov 4, 2014 | Sep 2014 | - | $306.60M | - |
| Aug 5, 2014 | Jun 2014 | - | $291.20M | - |
| May 8, 2014 | Mar 2014 | - | $246.90M | - |
| Feb 25, 2014 | Dec 2013 | - | $235.80M | - |
| Nov 5, 2013 | Sep 2013 | - | $232.20M | - |
| Aug 6, 2013 | Jun 2013 | - | $208.30M | - |
| May 7, 2013 | Mar 2013 | - | $196.20M | - |
| Feb 26, 2013 | Dec 2012 | - | $183.70M | - |
| Nov 8, 2012 | Sep 2012 | - | $175.50M | - |
| Aug 7, 2012 | Jun 2012 | - | $124.20M | - |
| May 8, 2012 | Mar 2012 | - | $102.50M | - |
| Feb 27, 2012 | Dec 2011 | - | $83.50M | - |
| Nov 1, 2011 | Sep 2011 | - | $73.30M | - |
| Jul 28, 2011 | Jun 2011 | - | $64.60M | - |
| May 3, 2011 | Mar 2011 | - | $50.90M | - |
| Mar 7, 2011 | Dec 2010 | - | $53.40M | - |
| Nov 4, 2010 | Sep 2010 | - | $44.80M | - |
| Aug 10, 2010 | Jun 2010 | - | $40.50M | - |
| May 5, 2010 | Mar 2010 | - | $35.20M | - |
| Mar 3, 2010 | Dec 2009 | - | $38.30M | - |
| Nov 5, 2009 | Sep 2009 | - | $30.80M | - |
| Aug 11, 2009 | Jun 2009 | - | $37.30M | - |
| May 7, 2009 | Mar 2009 | - | $22.10M | - |
| Mar 26, 2009 | Dec 2008 | - | $19.60M | - |
| Nov 13, 2008 | Sep 2008 | - | $17.80M | - |
| Aug 7, 2008 | Jun 2008 | - | $15.60M | - |
| May 13, 2008 | Mar 2008 | - | $14.60M | - |
| Feb 13, 2008 | Dec 2007 | - | $15.50M | - |
| Nov 6, 2007 | Sep 2007 | - | $21.50M | - |
| Aug 9, 2007 | Jun 2007 | - | $14.26M | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 1, 2022 | Dec 2021 | $3.09B | $3.09B | -0.00% |
| Feb 23, 2021 | Dec 2020 | $2.34B | $2.36B | 1.08% |
| Feb 25, 2020 | Dec 2019 | $2.14B | $2.16B | 0.95% |
| Feb 26, 2019 | Dec 2018 | $1.87B | $1.89B | 0.85% |
| Feb 27, 2018 | Dec 2017 | $1.62B | $1.62B | -0.28% |
| Feb 28, 2017 | Dec 2016 | - | $1.49B | - |
| Feb 23, 2016 | Dec 2015 | - | $1.32B | - |
| Feb 24, 2015 | Dec 2014 | - | $1.17B | - |
| Feb 25, 2014 | Dec 2013 | - | $872.40M | - |
| Feb 26, 2013 | Dec 2012 | - | $586.00M | - |
| Feb 27, 2012 | Dec 2011 | - | $272.30M | - |
| Mar 7, 2011 | Dec 2010 | - | $173.70M | - |
| Mar 3, 2010 | Dec 2009 | - | $128.40M | - |
| Mar 26, 2009 | Dec 2008 | - | $67.50M | - |
| Feb 13, 2008 | Dec 2007 | - | $65.30M | - |
JAZZ's next estimated earnings date (based on same quarter last year's report date) is Aug 3, 2022 for the fiscal quarter ending Jun 30, 2022.
Jazz Pharmaceuticals's previous earnings date was May 2, 2022 for its fiscal quarter ended Mar 31, 2022.
Jazz Pharmaceuticals's previous annual earnings date was Mar 1, 2022 for its fiscal year ended Dec 31, 2021.
JAZZ's earnings per share (EPS) was $16.23, beating the consensus analysts forecast of $15.68 by 3.51% , and higher than the previous year's EPS (Dec 2020) by 30.15%.
Revenues were $3.09B, worse than the forecast of $3.09B by -0.00%, and up by 30.91% from previous year's revenue.
The company reported a net income of $-329.67M.
Jazz Pharmaceuticals reported a free cash flow of $732.98M for its fiscal year, compared to $520.39M a year ago.
The company ended the fiscal year with $6.15B in total debt, an increase of 191.70% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
